[{"AccountsPayableCurrent_0_Q3_USD":6617000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":1486000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":19740000.0,"MarketableSecuritiesCurrent_0_Q3_USD":15815000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":7744257.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":8666000.0,"IncreaseDecreaseInDeferredLiabilities_3_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":34178000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":19795000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":-823000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":16440000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":84447000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":272000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":-4402000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":58800000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":667000.0,"LongTermDebtCurrent_0_Q3_USD":0.0,"InvestmentIncomeInterest_3_Q3_USD":2305000.0,"InvestmentIncomeInterest_1_Q3_USD":597000.0,"IncomeTaxesReceivable_0_Q3_USD":0.0,"InterestExpenseRelatedParty_3_Q3_USD":16000.0,"InterestExpenseRelatedParty_1_Q3_USD":16000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-1330000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-792000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-792000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_3_Q3_USD":-121000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-225406000.0,"AssetsFairValueDisclosure_0_Q3_USD":84169000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-72752000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_3_Q3_USD":0.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_3_Q3_USD":524000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_3_Q3_USD":10200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1_Q3_USD":1800000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":12237000.0,"RestrictedCashNoncurrent_0_Q3_USD":1374000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":32076000.0,"OtherNoncashIncomeExpense_3_Q3_USD":1174000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-1330000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-792000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.123,"OperatingLeaseRightOfUseAsset_0_Q3_USD":11491000.0,"OperatingLeasePayments_3_Q3_USD":1569000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":11399000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1449000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-86396000.0,"OperatingLeaseLiability_0_Q3_USD":12848000.0,"OperatingLeaseCost_1_Q3_USD":729000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":5326000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":720000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2939000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":3028000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":3127000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":3053000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":5307000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":18174000.0,"LeaseCost_3_Q3_USD":1888000.0,"LeaseCost_1_Q3_USD":795000.0,"OperatingLeaseCost_3_Q3_USD":1767000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":4161000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-8400000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":354000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-726101000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2406000.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":113700000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":12086000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":824000.0,"NetIncomeLoss_3_Q3_USD":-224076000.0,"NetIncomeLoss_1_Q3_USD":-85604000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-201943000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-16460000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":145651000.0,"LiabilitiesCurrent_0_Q3_USD":53296000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":129507000.0,"Liabilities_0_Q3_USD":178395000.0,"StockholdersEquity_0_Q3_USD":-48888000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1892000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":191000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":59897000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":29142000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.64,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.96,"CommonStockValue_0_Q3_USD":2000.0,"CommonStockSharesOutstanding_0_Q3_shares":89787654.0,"CommonStockSharesIssued_0_Q3_shares":89787654.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":83073000.0,"AssetsCurrent_0_Q3_USD":110974000.0,"Assets_0_Q3_USD":129507000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":9506703.0,"AdditionalPaidInCapital_0_Q3_USD":678034000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":699000.0,"VariableLeaseCost_1_Q3_USD":66000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":88893579.0,"AccruedLiabilitiesCurrent_0_Q3_USD":45214000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2768700.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":340360.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2857183.0,"OtherAssetsNoncurrent_0_Q3_USD":4636000.0,"LongTermDebtNoncurrent_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7744257.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1151000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":567000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1446000.0,"GainsLossesOnExtinguishmentOfDebt_0_Q3_USD":-4900000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-4851000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":-4851000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":-0.0031,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":84750114.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":-0.0022,"ShareBasedCompensation_3_Q3_USD":34178000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":150847000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":48927000.0,"OperatingIncomeLoss_3_Q3_USD":-223377000.0,"OperatingIncomeLoss_1_Q3_USD":-85413000.0,"OperatingExpenses_3_Q3_USD":210744000.0,"OperatingExpenses_1_Q3_USD":78069000.0,"InterestPayableCurrent_0_Q3_USD":0.0,"InterestExpense_3_Q3_USD":11222000.0,"InterestExpense_1_Q3_USD":3641000.0,"CommonStockSharesAuthorized_0_Q3_shares":564111242.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":80548.0,"VariableLeaseCost_3_Q3_USD":121000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200210"}]